Article
Early use of clinical <i>BRCA1/2</i> testing: Associations with race and breast cancer risk
7 Oct 2002
Abstract excerpt
When BRCA1/2 testing became commercially available in 1996, many U.S. experts voiced concern about the potential for indiscriminate use of testing among low-risk women. Supporting this concern, several early surveys of interest in genetic testing suggested that genetic testing for cancer susceptibility might appeal most to individuals at low risk of carrying a mutation. To identify factors associated with early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
